Vitiligo epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Gender) |
|||
| (11 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Autoimmune diseases and a family history of vitiligo are considered risk factors for developing this condition. A patient that has a relative with vitiligo has an 18 fold increased risk of developing the disease and having an earlier onset of the disease. | |||
==Epidemiology== | ==Epidemiology== | ||
===Prevalence=== | ===Prevalence=== | ||
* The prevalence of vitiligo is | * The prevalence of vitiligo is 1,000/100,000 (1%) of the population. | ||
* | * The prevalence varies from 100/100,000 (0.1%) up to more than 2,000/100,000 (2%) depending upon the country and age group.<ref>{{Cite journal | ||
| author = [[Christian Kruger]] & [[Karin Uta Schallreuter]] | | author = [[Christian Kruger]] & [[Karin Uta Schallreuter]] | ||
| title = A review of the worldwide prevalence of vitiligo in children/adolescents and adults | | title = A review of the worldwide prevalence of vitiligo in children/adolescents and adults | ||
| Line 22: | Line 22: | ||
| pmid = 22458952 | | pmid = 22458952 | ||
}}</ref> | }}</ref> | ||
* | * A higher prevalence has been observed in India, Romania, Uzbekistan and China.<ref>{{Cite journal | ||
| author = [[Christian Kruger]] & [[Karin Uta Schallreuter]] | | author = [[Christian Kruger]] & [[Karin Uta Schallreuter]] | ||
| title = A review of the worldwide prevalence of vitiligo in children/adolescents and adults | | title = A review of the worldwide prevalence of vitiligo in children/adolescents and adults | ||
| Line 50: | Line 50: | ||
===Gender=== | ===Gender=== | ||
* While the majority of | * While the majority of studies state that both sexes are equally affected,<ref>{{Cite journal | ||
| author = [[Virendra N. Sehgal]] & [[Govind Srivastava]] | | author = [[Virendra N. Sehgal]] & [[Govind Srivastava]] | ||
| title = Vitiligo: compendium of clinico-epidemiological features | | title = Vitiligo: compendium of clinico-epidemiological features | ||
| Line 60: | Line 60: | ||
| month = May-June | | month = May-June | ||
| pmid = 17558045 | | pmid = 17558045 | ||
}}</ref> some studies report a higher incidence in young women.<ref>{{Cite journal | }}</ref> some studies report a higher incidence of vitiligo in young women.<ref>{{Cite journal | ||
| author = [[Asem Alkhateeb]], [[Pamela R. Fain]], [[Anthony Thody]], [[Dorothy C. Bennett]] & [[Richard A. Spritz]] | |||
| title = Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families | |||
| journal = [[Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society]] | |||
| volume = 16 | |||
| issue = 3 | |||
| pages = 208–214 | |||
| year = 2003 | |||
| month = June | |||
| pmid = 12753387 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Kyriakos P. Kyriakis]], [[Ioulios Palamaras]], [[Efrosyni Tsele]], [[Charalambos Michailides]] & [[Sofia Terzoudi]] | | author = [[Kyriakos P. Kyriakis]], [[Ioulios Palamaras]], [[Efrosyni Tsele]], [[Charalambos Michailides]] & [[Sofia Terzoudi]] | ||
| title = Case detection rates of vitiligo by gender and age | | title = Case detection rates of vitiligo by gender and age | ||
| Line 72: | Line 82: | ||
| pmid = 19261030 | | pmid = 19261030 | ||
}}</ref> | }}</ref> | ||
* Females are diagnosed | * Females are diagnosed at a younger age than men. | ||
===Race=== | ===Race=== | ||
* There is no difference | * There is no difference in the prevalence among races. | ||
* The disease is more often noticed in dark skin patients, and may have a greater psychological impact in dark skin patients. | |||
==References== | ==References== | ||
Latest revision as of 13:30, 27 June 2014
|
Vitiligo Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vitiligo epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Vitiligo epidemiology and demographics |
|
Risk calculators and risk factors for Vitiligo epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Autoimmune diseases and a family history of vitiligo are considered risk factors for developing this condition. A patient that has a relative with vitiligo has an 18 fold increased risk of developing the disease and having an earlier onset of the disease.
Epidemiology
Prevalence
- The prevalence of vitiligo is 1,000/100,000 (1%) of the population.
- The prevalence varies from 100/100,000 (0.1%) up to more than 2,000/100,000 (2%) depending upon the country and age group.[1]
- A higher prevalence has been observed in India, Romania, Uzbekistan and China.[2]
Age
- 50% of patients with vitiligo are diagnosed before the age of 20. [3]
Gender
- While the majority of studies state that both sexes are equally affected,[4] some studies report a higher incidence of vitiligo in young women.[5][6]
- Females are diagnosed at a younger age than men.
Race
- There is no difference in the prevalence among races.
- The disease is more often noticed in dark skin patients, and may have a greater psychological impact in dark skin patients.
References
- ↑ Christian Kruger & Karin Uta Schallreuter (2012). "A review of the worldwide prevalence of vitiligo in children/adolescents and adults". International journal of dermatology. 51 (10): 1206–1212. doi:10.1111/j.1365-4632.2011.05377.x. PMID 22458952. Unknown parameter
|month=ignored (help) - ↑ Christian Kruger & Karin Uta Schallreuter (2012). "A review of the worldwide prevalence of vitiligo in children/adolescents and adults". International journal of dermatology. 51 (10): 1206–1212. doi:10.1111/j.1365-4632.2011.05377.x. PMID 22458952. Unknown parameter
|month=ignored (help) - ↑ Virendra N. Sehgal & Govind Srivastava (2007). "Vitiligo: compendium of clinico-epidemiological features". Indian journal of dermatology, venereology and leprology. 73 (3): 149–156. PMID 17558045. Unknown parameter
|month=ignored (help) - ↑ Virendra N. Sehgal & Govind Srivastava (2007). "Vitiligo: compendium of clinico-epidemiological features". Indian journal of dermatology, venereology and leprology. 73 (3): 149–156. PMID 17558045. Unknown parameter
|month=ignored (help) - ↑ Asem Alkhateeb, Pamela R. Fain, Anthony Thody, Dorothy C. Bennett & Richard A. Spritz (2003). "Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families". Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. 16 (3): 208–214. PMID 12753387. Unknown parameter
|month=ignored (help) - ↑ Kyriakos P. Kyriakis, Ioulios Palamaras, Efrosyni Tsele, Charalambos Michailides & Sofia Terzoudi (2009). "Case detection rates of vitiligo by gender and age". International journal of dermatology. 48 (3): 328–329. doi:10.1111/j.1365-4632.2009.03770.x. PMID 19261030. Unknown parameter
|month=ignored (help)